U.S. REITS Stock News

What recent returns suggest about Schneider National (SNDR) With no single headline event driving attention, Schneider National (SNDR) has drawn interest after its stock showed gains over the past month and past three months, alongside reported annual revenue and net income growth. See our latest analysis for Schneider National. The recent share price move to US$37.21, alongside a 20.4% 1 month and 45.1% 3 month share price return, comes on top of a 56.8% 1 year total shareholder return. This...

ICF International (ICFI) has recently drawn investor attention after a period of mixed share performance, with the stock down about 5% over the past month and roughly 8% over the past 3 months. See our latest analysis for ICF International. Those shorter term moves sit against a weaker backdrop, with the stock’s 1 year total shareholder return down 16.4% and its 5 year total shareholder return down 24.0%. This suggests momentum has been fading despite the recent uptick and current share price...

EastGroup Properties overview after recent trading performance EastGroup Properties (EGP) has drawn fresh investor attention after a recent pullback, with the stock down around 2% over the past month even as the past 3 months show a gain. At a recent close of US$198.21 and a market value of about US$10.6b, the industrial-focused real estate investment trust sits against a backdrop of annual revenue of US$735.38 million and net income of US$292.60 million. See our latest analysis for EastGroup...

AtriCure recently reported strong Q1 2026 earnings and confirmed that its BoxX-NoAF atrial fibrillation trial is running 12 months ahead of schedule, with patient enrollment now expected to be completed by the end of 2026. This faster clinical timeline, combined with momentum in its pain management segment, may tighten the feedback loop between trial outcomes, product adoption, and AtriCure’s long-term growth ambitions. Next, we’ll examine how the accelerated BoxX-NoAF enrollment timeline...

Hedge fund exit puts Enovix under fresh scrutiny Long Cast Advisors’ decision to exit Enovix (ENVX) after the departure of a key manufacturing process lead ahead of a major product launch has sharpened investor focus on the company’s execution risks. See our latest analysis for Enovix. The latest exit and management change come after a sharp 12.9% one day share price decline and 8.8% 7 day share price decline, despite a 50.1% 90 day share price return and a weaker 12 month total shareholder...

ServisFirst Bancshares (SFBS) is back on income investors’ radar after announcing a 13.4% increase in its annualized dividend, supported by a forecast of double digit earnings growth for the current fiscal year. See our latest analysis for ServisFirst Bancshares. At a share price of $78.15, ServisFirst’s 8.81% year to date share price return and 6.0% one year total shareholder return suggest steady, dividend focused sentiment, while the much stronger 87.25% three year total shareholder return...

In early June 2026, Houlihan Lokey reported softer quarterly results amid valuation concerns but continued to strengthen its franchise by hiring senior bankers such as Dave Buscaglia in Business Services and Bodo Krug von Nidda in Capital Solutions to expand coverage in specialty consulting, risk services, and GP-led real estate secondaries. These hires deepen Houlihan Lokey’s expertise in capital solutions and business services at a time when investors are questioning how its growth plans,...

Muted income trends put Republic Bancorp under the microscope Fresh commentary on Republic Bancorp (RBCA.A) has focused on its slower net interest income growth relative to peers over the past five years, with analysts also highlighting expectations for softer profitability in the coming year. This has brought the stock into sharper focus for investors who are considering whether recent share price strength, including gains over the past month and past three months, continues to align with...

NMI Holdings (NMIH) is back in focus after recent financial updates highlighted strong capital accumulation, improved profitability from fixed cost leverage, and a 17.3% return on equity, prompting fresh scrutiny of the stock’s recent moves. See our latest analysis for NMI Holdings. The share price has firmed in the very short term, with a 1-day share price return of 1.30% and 7-day share price return of 1.81%, but is still down 10% year to date. At the same time, the 3-year total shareholder...

Lamar Advertising: Dividend Signals and Digital Growth Come Into Focus Recent commentary around Lamar Advertising (LAMR) has centered on management reaffirming full year AFFO guidance and indicating room for a higher dividend if current business trends hold. See our latest analysis for Lamar Advertising. The recent reaffirmation of full year AFFO guidance and commentary on dividend capacity arrives as the stock trades at US$151.42, with a 30 day share price return of 7.28% and a 1 year total...

Colgate-Palmolive recently appointed Samir Singh as president of enterprise oral care and promoted long-time executive Ram Raghavan to chief marketing officer, reshaping leadership across its flagship global oral care and marketing functions. These appointments bring deep fast-moving consumer goods experience into Colgate-Palmolive’s top ranks, potentially influencing how the company manages global brands, innovation and category growth initiatives. We'll now examine how Samir Singh’s...

If you are wondering whether Roper Technologies at around US$332 per share offers value or just reflects past enthusiasm, the starting point is to separate price moves from underlying worth. The stock is up about 2% over the past week, but remains down around 5.2% over the past month and has fallen about 23.6% year to date and 41.6% over the last 12 months, which can change how investors view both upside potential and risk. Recent coverage has focused on how software and technology companies...

Zymeworks (ZYME) stock has been reacting to a series of clinical and regulatory milestones, including new Phase 1 data, a U.S. PDUFA date, and a China filing for its HER2 targeted therapy. See our latest analysis for Zymeworks. Despite the recent clinical and regulatory progress, Zymeworks shares have come under pressure in the short term, with the 1 month share price return down 12.93% and the year to date share price return down 9.69%. However, the 1 year total shareholder return of 90.79%...

Global-E Online (NasdaqGS:GLBE) has put a fresh US$500 million share repurchase program on the table, following completion of most of its prior US$200 million plan and signaling management confidence in ongoing cash generation. See our latest analysis for Global-E Online. Despite the new US$500 million buyback authorization and the pending Passport acquisition, Global-E Online's recent share price performance has been mixed. The 7 day share price return is 4.86%, while the year to date share...

Recent performance and context for American Superconductor American Superconductor (AMSC) has drawn fresh attention after recent trading, with the stock closing at US$42.34. Investors are weighing its share price moves over the past month and the past 3 months against the company’s broader fundamentals. See our latest analysis for American Superconductor. Recent trading has been choppy, with the share price down 16.9% over the past week and 25.8% over the past month, even after a strong 3...

Context for Telephone and Data Systems stock Telephone and Data Systems (TDS) has drawn investor attention after recent trading left the stock down about 14% over the month and about 13% over the past 3 months, in contrast with a positive 1 year total return. See our latest analysis for Telephone and Data Systems. At a share price of US$39.16, TDS has given investors a mixed ride, with shorter term share price returns weaker while the 1 year and multi year total shareholder returns remain...

In recent days, The Vita Coco Company reported Q1 2026 results showing net sales rising 37% year over year, expanded operating margins, and raised full-year guidance, while management highlighted its roughly 51%–52% share of the U.S. branded coconut water market and growing international presence. At the same time, analysts have become more positive on Vita Coco’s earnings outlook, emphasizing the combination of strong category position, margin expansion, and updated guidance as key supports...

In early June 2026, Snowflake named TransUnion its 2026 Media and Entertainment Product Partner of the Year, as TransUnion also expanded TruIQ Data Enrichment on the Snowflake AI Data Cloud to support prescreen credit marketing directly within customers’ Snowflake environments. This combination of recognition and product expansion underscores how deeply TransUnion’s privacy-focused identity and credit data capabilities are being integrated into cloud-based marketing and analytics...

Reports that Sleep Number is preparing for bankruptcy, with potential store closures, have put Somnigroup International (SGI) back in focus as investors consider how nearby Mattress Firm locations might benefit from shifting customer traffic. See our latest analysis for Somnigroup International. Somnigroup’s share price has come under pressure recently, falling 13.5% over the past month and 23.4% year to date. However, the 3 year total shareholder return of 85.5% and 5 year total shareholder...

FBI armor contract puts Cadre Holdings (CDRE) in focus Cadre Holdings (CDRE) is back on investor radar after subsidiary Safariland was selected as the ballistic panel provider for Predictive Ballistics' Overt Armor Kit under a five year, $61 million FBI contract. See our latest analysis for Cadre Holdings. Despite the FBI contract putting fresh attention on the business, Cadre Holdings’ share price is down 31% over the past 90 days and 27% year to date. However, the 3 year total shareholder...

Integra LifeSciences Holdings: Recent Performance Snapshot Integra LifeSciences Holdings (IART) has attracted fresh attention after a strong share price move over the past 3 months, with the stock up about 75%, alongside a monthly gain above 20%. See our latest analysis for Integra LifeSciences Holdings. While the recent 30 day share price return of 21.36% and 90 day share price return of 74.61% suggest strong short term momentum, the 3 year total shareholder return is down 58.17%, indicating...

Texas Attorney General Ken Paxton has opened a formal investigation into Celsius Holdings and its Alani Nu subsidiary over past marketing of high‑caffeine energy drinks to children and teenagers, following a lawsuit alleging a teenager’s death linked to excessive consumption. The probe puts Celsius’s youth‑oriented branding and safety claims under legal scrutiny, testing how its growth-focused marketing approach aligns with consumer protection standards. We’ll now examine how this...

DocuSign (DOCU) has kicked off Q1 2027 with total revenue of US$830.2 million and basic EPS of US$0.40, setting the stage for investors to reassess how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$763.7 million in Q1 2026 to US$830.2 million in Q1 2027, while basic EPS shifted from US$0.35 to US$0.40 over the same stretch, giving you a clear read on how sales and earnings are tracking into the new fiscal year as margins come under...

A law firm has opened an investigation into Roblox (NYSE:RBLX) over potential fraud, negligence, or other unlawful practices, raising fresh questions about governance and legal risk for the platform. Separately, Roblox is overhauling its discovery algorithm to emphasize deeper user engagement and long term retention instead of immediate monetization. The company is aiming to improve content quality and appeal more to adult users. Roblox runs a global user generated gaming and experiences...